BIOequity Europe 2022
May 17, 2022 at 2:30 PM CEST
Tuesday May 17, 2:30-3:30 p.m. CET
West-East Roundtable: The Clinical Pathway to Europe-China Collaborations
Session Chair & Panelists:
- Joshua Berlin, Head of Business Development, BioCentury Inc. (Session Chair)
- Georg Büchner, Ph.D., Group Chief Business Officer, Helsinn Group
- James Huang, Founding Managing Partner, Panacea Healthcare Venture; Managing Partner, KPCB China
- Stefania Mazzoleni Ph.D., Scientific Project Manager & Communication Officer, Genenta Science S.p.A
- Steven Powell, Ph.D., CEO, eTheRNA immunotherapies N.V.
- Debra Yu, M.D., President & Chief Strategy Officer, LianBio
- Guo-Liang Yu, Ph.D., Chairman, BayHelix; Co-Founder, Chairman & CEO, Apollomics Inc.